Natterman

Dry extract of Hederae folium, the active ingredient in Natterman, is a herbal preparation presented as a standardized dry extract for oral use. It is traditionally employed to support the respiratory tract, helping to ease cough, promote mucus clearance and reduce bronchial irritation in adult patients and is often used under medical supervision.

GNH USA supplies Natterman as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution.

Natterman, a herbal dry extract of Hederae folium, is used to support the respiratory tract and airway function.

Acute bronchitis: helps alleviate cough and improve mucus clearance Chronic obstructive pulmonary disease (COPD) symptom relief: may reduce bronchial irritation and promote easier breathing Upper respiratory tract infection cough: assists in soothing irritated throat and reducing cough frequency

Adverse reactions have been reported with oral ivy leaf extracts.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset - Allergic skin reaction: rash or itching - Taste disturbance: bitter aftertaste

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis, swelling of face or throat - Bronchospasm: paradoxical tightening of airways - Liver enzyme elevation: abnormal liver function tests

When considering Natterman, certain safety measures are recommended. - Pregnancy: safety not established; avoid unless prescribed by a physician - Breastfeeding: insufficient data; use with caution and medical guidance - Asthma patients: monitor for possible bronchospasm - Concomitant use with other expectorants: may increase risk of gastrointestinal upset - Drug interactions: inform healthcare provider of all herbal and prescription medicines being taken - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight

Potential interactions with other medicines should be reviewed.

Major Interactions (Avoid): - Anticoagulant therapy (e.g., warfarin, heparin): may increase bleeding risk - Beta‑blockers: may diminish bronchodilatory effect of the extract

Moderate Interactions (Monitor Closely): - Other expectorants or mucolytics: additive effect may cause GI irritation - Cough suppressants (e.g., codeine): may reduce the expectorant action - Herbal supplements containing saponins: possible additive pharmacologic effects